Incyte Corporation

Incyte Corporation Stock

60.63P/E
€21.86BMarket capitalisation
US$1.96Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes an array of oncology and dermatology programs.

Incyte Corporation is registered in the following country: United States of America (Exchange: USNASD).

Key metrics

Key metrics and master data for the Incyte Corporation stock.

Market capitalisation
€21.86B
P/E
60.63
P/B
3.26
P/S
4.11
P/CF
12.26
Issued shares 204M Units

Return

Here you can see the performance of the Incyte Corporation stock.

PeriodPerfor­mance
1 Week-3.10 %
1 Month+5.04 %
3 Months-1.07 %
6 Months-11.36 %
1 Year+37.33 %
YTD-6.10 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the Incyte Corporation share.

DateRatio
No data available.

Which ETF contains the Incyte Corporation stock?

The Incyte Corporation stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Incyte Corporation has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Incyte Corporation stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.